Abivax - ADR
ABVX
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.61B
Close$
$7.82
93.8% downside
Current Fair Value
93.8% downsideOvervalued by 93.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.61 Billion |
|---|---|
| Enterprise Value | $9.13 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.65 |
| Beta | -0.21 |
| Outstanding Shares | 69,527,315 |
Return
| Return on Equity | -90.32% |
|---|---|
| Return on Assets | -70.36% |
| Return on Invested Capital | -62.80% |
Valuation & Multiples
| P/E Ratio | -23.62 |
|---|---|
| PEG | -6.39 |
| Price to Sales | - |
| Price to Book Ratio | 20.92 |
| Enterprise Value to Revenue | 1692.03 |
| Enterprise Value to EBIT | -27.9 |
| Enterprise Value to Net Income | -23 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 1, 2026
EPS Estimate
$-0.92
Average shareholder expectationRevenue Estimate
$602,961
Average shareholder expectationNext Earnings Call
Expected Date
September 14, 2026
EPS Estimate
$-0.96
Average shareholder expectationRevenue Estimate
$778,451
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2087▼ 38.91% |
|---|---|
| Total Calls | 124,318▼ 93.28% |
| Total Puts | 25,944▼ 97.65% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 6.18%▼ 65.79% |
|---|---|
| Total Invested | $567.96M▼ 89.73% |
| Investors Holding | 119▼ 167.00% |
ESG Score
No data